Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ADVANCED POLYMER SYSTEMS TO FILE NDA FOR PROZONE UVA/UVB PROTECTANT

This article was originally published in The Rose Sheet

Executive Summary

ADVANCED POLYMER SYSTEMS TO FILE NDA FOR PROZONE UVA/UVB PROTECTANT during the second quarter of 1994, the company announced Feb. 15. The Redwood City, CA-based firm noted that Phase III safety-in-use trials for ProZone, a prescription melanin-based UVA/UVB sun protectant, have been completed and that Phase III efficacy studies "are nearly completed." Advanced Polymer Systems said it currently is engaged in discussions with FDA "to identify and clarify any potential issues prior to the NDA filing."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

RS000159

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel